{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:07:47Z","timestamp":1793333267378,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"General Project Liaoning Provincial Education Department","award":["JCZR2020004"],"award-info":[{"award-number":["JCZR2020004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1245\/s10434-021-11316-z","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T16:03:11Z","timestamp":1645113791000},"page":"3170-3186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages"],"prefix":"10.1245","volume":"29","author":[{"given":"Jian-Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Gang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"11316_CR1","doi-asserted-by":"crossref","unstructured":"Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of Gastrointestinal Cancer. Gastroenterology. 2020;159(1):335\u2013349.","DOI":"10.1053\/j.gastro.2020.02.068"},{"key":"11316_CR2","doi-asserted-by":"crossref","unstructured":"Doescher J, Veit JA, Hoffmann TK 2017 The 8th edition of the AJCC Cancer Staging Manual. HNO 65:956\u2013961.","DOI":"10.1007\/s00106-017-0391-3"},{"key":"11316_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"11316_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","volume":"42","author":"Y Yonemura","year":"2016","unstructured":"Yonemura Y, Canbay E, Li Y, et al. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol. 2016;42:1123\u201331.","journal-title":"Eur J Surg Oncol."},{"key":"11316_CR5","first-page":"224","volume":"83","author":"L Bijelic","year":"2012","unstructured":"Bijelic L, Sugarbaker PH. The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer. Ann Italiani Chir. 2012;83:224\u201331.","journal-title":"Ann Italiani Chir."},{"key":"11316_CR6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer."},{"key":"11316_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/CMAR.S149619","volume":"10","author":"R Sitarz","year":"2018","unstructured":"Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manage Res. 2018;10:239\u201348.","journal-title":"Cancer Manage Res."},{"key":"11316_CR8","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1007\/s00464-015-4702-z","volume":"30","author":"L Zou","year":"2016","unstructured":"Zou L, Xiong W, Mo D, et al. Totally laparoscopic complete bursectomy and D2 lymphadenectomy in radical total gastrectomy: an outside bursa omentalis approach. Surg Endosc. 2016;30:4152.","journal-title":"Surg Endosc."},{"key":"11316_CR9","doi-asserted-by":"crossref","unstructured":"Kuramoto M, Shimada S, Ikeshima S, et al. A proposal of a practical and optimal prophylactic strategy for peritoneal recurrence. J Oncol. 2012;2012:340380.","DOI":"10.1155\/2012\/340380"},{"key":"11316_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","volume":"87","author":"CH Yoo","year":"2000","unstructured":"Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236\u201342.","journal-title":"Br J Surg."},{"key":"11316_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/bjs.1800770425","volume":"77","author":"T Boku","year":"1990","unstructured":"Boku T, Nakane Y, Minoura T, et al. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg. 1990;77:436\u20139.","journal-title":"Br J Surg."},{"key":"11316_CR12","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1245\/s10434-011-1620-8","volume":"18","author":"T-S Han","year":"2011","unstructured":"Han T-S, Kong S-H, Lee H-J, et al. Dissemination of free cancer cells from the gastric lumen and from perigastric lymphovascular pedicles during radical gastric cancer surgery. Ann Surg Oncol. 2011;18:2818\u201325.","journal-title":"Ann Surg Oncol."},{"key":"11316_CR13","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"X-J Yang","year":"2011","unstructured":"Yang X-J, Huang C-Q, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575\u201381.","journal-title":"Ann Surg Oncol."},{"key":"11316_CR14","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387\u201393.","journal-title":"J Clin Oncol."},{"issue":"3","key":"11316_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/cancers11030399","volume":"11","author":"A Petrillo","year":"2019","unstructured":"Petrillo A, Pompella L, Tirino G, et al. Perioperative treatment in resectable gastric cancer: current perspectives and future directions. Cancers (Basel). 2019;11(3):399.","journal-title":"Cancers"},{"key":"11316_CR16","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1200\/JCO.2014.58.3930","volume":"33","author":"SH Park","year":"2015","unstructured":"Park SH, Sohn TS, Lee J, et al. Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol. 2015;33:3130\u20136.","journal-title":"J Clin Oncol."},{"key":"11316_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jso.21052","volume":"98","author":"F Bozzetti","year":"2008","unstructured":"Bozzetti F, Yu W, Baratti D, Kusamura S, Deraco M. Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol. 2008;98:273\u20136.","journal-title":"J Surg Oncol."},{"key":"11316_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5230\/jgc.2018.18.e32","volume":"18","author":"D-W Kim","year":"2018","unstructured":"Kim D-W, Park D-G, Song S, Jee YS. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as treatment options for peritoneal metastasis of advanced gastric cancer. J Gastric Cancer. 2018;18:296\u2013304.","journal-title":"J Gastric Cancer."},{"key":"11316_CR19","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol."},{"key":"11316_CR20","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol."},{"key":"11316_CR21","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol."},{"issue":"79","key":"11316_CR22","first-page":"1","volume":"2017","author":"J Desiderio","year":"1990","unstructured":"Desiderio J, Chao J, Melstrom L, et al. The 30-year experience: a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer Oxford Engl. 1990;2017(79):1\u201314.","journal-title":"Eur J Cancer Oxford Engl."},{"key":"11316_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12885-021-07925-2","volume":"21","author":"B Fan","year":"2021","unstructured":"Fan B, Bu Z, Zhang J, et al. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC cancer. 2021;21:216.","journal-title":"BMC cancer."},{"key":"11316_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4251\/wjgo.v12.i7.782","volume":"12","author":"T-Y Xie","year":"2020","unstructured":"Xie T-Y, Wu D, Li S, et al. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer. World J Gastrointest Oncol. 2020;12:782\u201390.","journal-title":"World J Gastrointest Oncol."},{"key":"11316_CR25","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1186\/s12885-019-6125-z","volume":"19","author":"MK Beeharry","year":"2019","unstructured":"Beeharry MK, Zhu Z-L, Liu W-T, Yao X-X, Yan M, Zhu Z-G. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer. 2019;19:932.","journal-title":"BMC Cancer."},{"key":"11316_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3892\/etm.2014.1599","volume":"7","author":"H-B Cui","year":"2014","unstructured":"Cui H-B, Ge H-E, Bai X-Y, et al. Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer. Exp Therapeutic Med. 2014;7:1083\u20138.","journal-title":"Exp Therapeutic Med."},{"key":"11316_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110:275\u201384.","journal-title":"J Surg Oncol."},{"key":"11316_CR28","first-page":"229","volume":"37","author":"H Zhan","year":"2010","unstructured":"Zhan H, Liang H, Wang B, Deng J, Hao X. Efficacy of intraoperative hyperthermic peritoneal perfusion on 60 patients with advanced gastric carcinoma. Chinese J Clin Oncol. 2010;37:229\u201331.","journal-title":"Chinese J Clin Oncol."},{"key":"11316_CR29","first-page":"295","volume":"29","author":"HJ Deng","year":"2009","unstructured":"Deng HJ, Wei ZG, Zhen L, Li GX, Uang XC, Qing SH. Nan fang yi ke da xue xue bao [clinical application of perioperative continuous hyperthermic peritoneal perfusion chemotherapy for gastric cancer]. J Southern Med Univ. 2009;29:295\u20137.","journal-title":"J Southern Med Univ"},{"key":"11316_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/SLA.0b013e3181b0c80e","volume":"250","author":"M Kuramoto","year":"2009","unstructured":"Kuramoto M, Shimada S, Ikeshima S, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009;250:242\u20136.","journal-title":"Ann Surg."},{"key":"11316_CR31","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.ejso.2019.07.030","volume":"45","author":"MY Reutovich","year":"2019","unstructured":"Reutovich MY, Krasko OV, Sukonko OG. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients. Eur J Surg Oncol. 2019;45:2405\u201311.","journal-title":"Eur J Surg Oncol."},{"key":"11316_CR32","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1245\/s10434-016-5306-0","volume":"23","author":"T Boerner","year":"2016","unstructured":"Boerner T, Graichen A, Jeiter T, et al. CRS-HIPEC prolongs survival but is not curative for patients with peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol. 2016;23:3972\u20137.","journal-title":"Ann Surg Oncol."},{"key":"11316_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jcma.2013.04.004","volume":"76","author":"L-Y Kang","year":"2013","unstructured":"Kang L-Y, Mok K-T, Liu S-I, et al. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. JCMA J Chinese Med Assoc. 2013;76:425\u201331.","journal-title":"JCMA J Chinese Med Assoc."},{"key":"11316_CR34","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12885-020-07339-6","volume":"20","author":"L Zhu","year":"2020","unstructured":"Zhu L, Xu Z, Wu Y, et al. Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study. BMC Cancer. 2020;20:827.","journal-title":"BMC Cancer."},{"key":"11316_CR35","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.2147\/CMAR.S249838","volume":"12","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Zhang J, Bai X, et al. Lobaplatin in prophylactic hyperthermic intraperitoneal chemotherapy for advanced gastric cancer: safety and efficacy profiles. Cancer Manage Res. 2020;12:5141\u20136.","journal-title":"Cancer Manage Res."},{"key":"11316_CR36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jso.25823","volume":"121","author":"TP Diniz","year":"2020","unstructured":"Diniz TP, da Costa WL, Fonseca de Jesus VH, et al. Does HIPEC improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity score-matched analysis. J Surg Oncol. 2020;121:823\u201332.","journal-title":"J Surg Oncol."},{"key":"11316_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/0284186X.2011.594809","volume":"51","author":"B Hultman","year":"2012","unstructured":"Hultman B, Lundkvist J, Glimelius B, Nygren P, Mahteme H. Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer. Acta Oncologica Stockholm, Sweden. 2012;51:112\u201321.","journal-title":"Acta Oncologica Stockholm, Sweden."},{"key":"11316_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/02656736.2014.893451","volume":"30","author":"RR Yarema","year":"2014","unstructured":"Yarema RR, Ohorchak MA, Zubarev GP, et al. Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study. Int J Hyperthermia. 2014;30:159\u201365.","journal-title":"Int J Hyperthermia."},{"key":"11316_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.amjsurg.2013.04.010","volume":"207","author":"KW Kim","year":"2014","unstructured":"Kim KW, Chow O, Parikh K, et al. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy. Am J Surg. 2014;207:78\u201383.","journal-title":"Am J Surg."},{"key":"11316_CR40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s10120-019-00969-1","volume":"22","author":"B Rau","year":"2019","unstructured":"Rau B, Brandl A, Thuss-Patience P, et al. The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis. Gastric Cancer. 2019;22:1226\u201337.","journal-title":"Gastric Cancer."},{"key":"11316_CR41","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"P-E Bonnot","year":"2019","unstructured":"Bonnot P-E, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028\u201340.","journal-title":"J Clin Oncol."},{"key":"11316_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jso.21628","volume":"102","author":"C Li","year":"2010","unstructured":"Li C, Yan M, Chen J, et al. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination. J Surg Oncol. 2010;102:361\u20135.","journal-title":"J Surg Oncol."},{"key":"11316_CR43","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1186\/s12885-019-6411-9","volume":"19","author":"MK Beeharry","year":"2019","unstructured":"Beeharry MK, Zhu ZL, Liu WT, Yao XX, Yan M, Zhu ZG. Correction to: prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer. 2019;19:1256.","journal-title":"BMC Cancer."},{"key":"11316_CR44","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.ejso.2020.11.139","volume":"47","author":"Z-H Ji","year":"2021","unstructured":"Ji Z-H, Yu Y, Liu G, et al. Peritoneal cancer index (PCI)-based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: a single-center retrospective analysis of 125 patients. Eur J Surg Oncol. 2021;47:1411\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"11316_CR45","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1245\/s10434-020-08234-x","volume":"27","author":"A Bhatt","year":"2020","unstructured":"Bhatt A, Yonemura Y, Mehta S, et al. The Pathologic Peritoneal Cancer Index (PCI) strongly differs from the Surgical PCI in peritoneal metastases arising from various primary tumors. Ann Surg Oncol. 2020;27:2985\u201396.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"11316_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.gassur.2005.11.001","volume":"10","author":"U Ribeiro","year":"2016","unstructured":"Ribeiro U, Safatle-Ribeiro AV, Zilberstein B, et al. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg. 2006;10(2):170\u201377.","journal-title":"J Gastrointest Surg."},{"key":"11316_CR47","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ejso.2010.06.007","volume":"36","author":"M La Torre","year":"2010","unstructured":"La Torre M, Ferri M, Giovagnoli MR, et al. Peritoneal wash cytology in gastric carcinoma: prognostic significance and therapeutic consequences. Eur J Surg Oncol. 2010;36:982\u20136.","journal-title":"Eur J Surg Oncol."},{"key":"11316_CR48","doi-asserted-by":"publisher","first-page":"9549","DOI":"10.1038\/s41598-020-66637-y","volume":"10","author":"H-J Shim","year":"2020","unstructured":"Shim H-J, Kim H-J, Lee SH, et al. Observational study of peritoneal washing cytology-positive gastric cancer without gross peritoneal metastasis in patients who underwent radical D2 gastrectomy. Sci Rep. 2020;10:9549.","journal-title":"Sci Rep."},{"key":"11316_CR49","first-page":"295","volume":"29","author":"H-j Deng","year":"2009","unstructured":"Deng H-j, Wei Z-g, Zhen L, Li G-x, Uang X-c, Qing S-h. Nan fang yi ke da xue xue bao. [clinical application of perioperative continuous hyperthermic peritoneal perfusion chemotherapy for gastric cancer]. J Southern Med Univ. 2009;29:295\u20137.","journal-title":"J Southern Med Univ."},{"key":"11316_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S2468-1253(20)30315-0","volume":"6","author":"HK Yang","year":"2021","unstructured":"Yang HK, Ji J, Han SU, et al. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2021;6:120\u20137.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"1","key":"11316_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/bjs.11481","volume":"107","author":"K Misawa","year":"2019","unstructured":"Misawa K, Mochizuki Y, Sakai M, Teramoto H, Kodera Y. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial). Br J Surg. 2019;107(1):120.","journal-title":"Br J Surg."},{"issue":"1","key":"11316_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13304-021-01120-5","volume":"74","author":"S Li","year":"2022","unstructured":"Li S, Li L, Tan B, Wang J, Xue S. The benefits of surgery plus extensive intraoperative peritoneal lavage (EIPL) for patients with gastric cancer compared with surgery alone: a systematic review and meta-analysis. Updates Surg. 2022;74(1):65\u201372.","journal-title":"Updates Surg."},{"key":"11316_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4251\/wjgo.v2.i2.109","volume":"2","author":"TD Yan","year":"2010","unstructured":"Yan TD, Cao CQ, Munkholm-Larsen S. A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy. World J Gastrointest Oncol. 2010;2:109\u201316.","journal-title":"World J Gastrointest Oncol."},{"issue":"9","key":"11316_CR54","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/jcm10091899","volume":"10","author":"PH Sugarbaker","year":"2021","unstructured":"Sugarbaker PH. Prevention and treatment of peritoneal metastases from gastric cancer. J Clin Med. 2021;10(9):1899.","journal-title":"J Clin Med."},{"key":"11316_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.currproblcancer.2009.06.003","volume":"33","author":"P Shen","year":"2009","unstructured":"Shen P, Stewart JH, Levine EA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale. Curr Probl Cancer. 2009;33:125\u201341.","journal-title":"Curr Probl Cancer."},{"key":"11316_CR56","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.critrevonc.2015.04.004","volume":"95","author":"HJ Braam","year":"2015","unstructured":"Braam HJ, Schellens JH, Boot H, et al. Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer. Crit Rev Oncol Hematol. 2015;95:282\u201396.","journal-title":"Crit Rev Oncol Hematol."},{"key":"11316_CR57","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1186\/s12885-020-07601-x","volume":"20","author":"P Yu","year":"2020","unstructured":"Yu P, Ye Z, Dai G, et al. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. BMC Cancer. 2020;20:1108.","journal-title":"BMC Cancer."},{"key":"11316_CR58","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12013-014-0326-5","volume":"71","author":"O Huang","year":"2015","unstructured":"Huang O, Lu X, Xu X, Shi Y. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up. Cell Biochem Biophys. 2015;71:1171\u201380.","journal-title":"Cell Biochem Biophys."},{"key":"11316_CR59","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/jso.24771","volume":"116","author":"S Murata","year":"2017","unstructured":"Murata S, Yamamoto H, Naitoh H, et al. Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer. J Surg Oncol. 2017;116:1159\u201365.","journal-title":"J Surg Oncol."},{"key":"11316_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2407-14-183","volume":"14","author":"O Glehen","year":"2014","unstructured":"Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014;14:183.","journal-title":"BMC Cancer"},{"key":"11316_CR61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12885-019-5640-2","volume":"19","author":"WJ Koemans","year":"2019","unstructured":"Koemans WJ, van der Kaaij RT, Boot H, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer. 2019;19:420.","journal-title":"BMC Cancer."},{"key":"11316_CR62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12885-020-6701-2","volume":"20","author":"MK Beeharry","year":"2020","unstructured":"Beeharry MK, Ni Z-T, Yang ZY, et al. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial. BMC Cancer. 2020;20:224.","journal-title":"BMC Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-11316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-11316-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-11316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:36:21Z","timestamp":1700242581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-11316-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["11316"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-11316-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURE"}}]}}